Sera Prognostics Announces Positive Data from Second Study of Preterm Birth Test

SAN FRANCISCO, Feb. 12, 2011 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., a women’s health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced that preliminary analyses of data from a second study of predictive preterm birth biomarkers generally confirmed researchers’ earlier results and were able to identify up [...] http://bit.ly/eCO22f